A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
| Status: | Completed |
|---|---|
| Conditions: | Schizophrenia |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 11/16/2017 |
| Start Date: | June 2015 |
| End Date: | August 2016 |
A Randomized, Double-Blind, Placebo- and Active-Controlled, Multi-Center Study to Assess the Antipsychotic Efficacy of ITI-007 After 6 Weeks of Treatment in Patients With Schizophrenia
The study will evaluate the antipsychotic efficacy of ITI-007 in a randomized, double-blind,
parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with
schizophrenia having an acute exacerbation of psychosis.
parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with
schizophrenia having an acute exacerbation of psychosis.
Inclusion Criteria:
- male or female subjects of any race, ages 18-60 inclusive, with a clinical diagnosis
of schizophrenia
- experiencing an acute exacerbation of psychosis
Exclusion Criteria:
- any subject unable to provide informed consent
- any female subject who is pregnant or breast-feeding
- any subject judged to be medically inappropriate for study participation
We found this trial at
1
site
Click here to add this to my saved trials
